CATX•benzinga•
Perspective Therapeutics Announces First Patient Treated With PSV359 In Phase 1/2A Dose-Finding Trial Assessing Safety And Preliminary Anti-Tumor Activity
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 29, 2025 by benzinga